Exodus Point Capital Management, LP Oramed Pharmaceuticals Inc. Transaction History

Exodus Point Capital Management, LP

  • $16.4 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 19, 2022
SELL
$3.72 - $9.0 $68,169 - $164,925
-18,325 Closed
0 $0
Q1 2022

May 13, 2022
BUY
$8.19 - $13.89 $150,081 - $254,534
18,325 New
18,325 $159,000
Q2 2021

Aug 16, 2021
SELL
$8.34 - $14.59 $437,733 - $765,770
-52,486 Closed
0 $0
Q1 2021

May 17, 2021
BUY
$4.22 - $11.33 $221,490 - $594,666
52,486 New
52,486 $533,000

Others Institutions Holding ORMP

# of Institutions
63
Shares Held
7.4M
Call Options Held
4K
Put Options Held
2.1K
View Full List

About ORAMED PHARMACEUTICALS INC.

ORMP Quotes by TradingView
  • Ticker ORMP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 38,827,100
  • Market Cap $92M
  • Description
  • Oramed Pharmaceuticals Inc. engages in the research and development of pharmaceutical solutions for the treatment of diabetes and for the use of orally ingestible capsules or pills for delivery of polypeptides. Its proprietary flagship product is the ORMD-0801, an orally ingestible insulin capsule, which completed phase II clinical trials for th...
More about ORMP
Track This Portfolio

Track Exodus Point Capital Management, LP Portfolio

Follow Exodus Point Capital Management, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Exodus Point Capital Management, LP, based on Form 13F filings with the SEC.

News

Stay updated on Exodus Point Capital Management, LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email